Navigation Links
Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
Date:5/20/2009

psule formulation, greater efficacy and reduced side effects.
  • Sales of Sinobiopharma's formulation of L-alanyl-L-glutamine for parenteral (intravenous) nutrition are projected to exceed 30,000 units in 2009.
  • The Company is in the process of submitting its application for approval of Rocuronium bromide, a next generation skeletal muscle relaxant that is also the first that can be stored at room temperature, to the Chinese Food and Drug Administration (SFDA).

  • "In the first quarter of 2009, we saw strong demand for our existing products," said Lequn Huang, Company President and CEO. "We expect that increased marketing efforts and expanded distribution will help boost additional growth for the rest of 2009, with projected improvements in both margins and profitability."

    About Sinobiopharma

    Sinobiopharma, Inc. is a fully integrated and highly innovative biotechnology company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, the world's fastest growing pharmaceutical market. Known as Dong Ying (Jiangsu) Pharmaceutical Co. Ltd. in China, the Company's current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs.

        Contacts:
        Sinobiopharma, Inc.
        Investor Relations: 1-877-568-0188
    

    FORWARD LOOKING STATEMENTS This news release may include "forward-looking statements" regarding Sinobiopharma, Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiopharma, Inc. expresses or implies an expectation or belief as to future events or resu
    '/>"/>

    SOURCE Sinobiopharma, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
    2. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
    3. Sinobiopharma, Inc. Appoints New Director of Marketing
    4. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
    5. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
    6. Sinobiopharma Secures Rights to Seven Key Patents
    7. Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug Perindopril
    8. SemBioSys updates Apo AI development program
    9. Strategic Diagnostics Updates Roth Conference Presentation Time
    10. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
    11. SGX Pharmaceuticals Updates Date of Presentation at the BIO InvestorForum 2007
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... , Sept. 2, 2015 Australian prostate ... a prestigious Australian science prize recognising ,outstanding, science that ... track to globally launch a novel prostate cancer diagnostic ... a high level consortium taking out the peer-reviewed Australian ... Scientific Research. This prize is awarded ...
    (Date:9/2/2015)... 2, 2015 Aytu BioScience, Inc. (OTCQB: AYTU), ... urological and related conditions, announced today that it has ... convertible note financing, raising a total of $5.175 million, ... million. Josh Disbrow , Chief ... placement are intended to be used to conduct clinical ...
    (Date:9/2/2015)... Calif. , Sept. 2, 2015 Veracyte, ... Bonnie H. Anderson , president and chief executive officer, ... on Wednesday, September 16, 2015 at 10:30 a.m. ET ... The live audio webcast and subsequent replay ... The webcast will be available shortly after conclusion of ...
    (Date:9/2/2015)... TEL-AVIV, Israel , September 2, 2015 /PRNewswire/ ... BLGTY, TASE: BOLT) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, announced today ... treatment of glaucoma will be delivered at the ... of the European Society of Cataract & Refractive ...
    Breaking Biology Technology:Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
    ... 3 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today ... at the 9th Annual Needham Healthcare Conference on June 10 at ... New York City . , , ... webcast will be available through the Investor Relations page of the OncoGenex Web ...
    ... China , June 3 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc. (NYSE Amex: TPI ), ... at the Company,s website: , , , ... , , ... , , ...
    ... Caliper Life Sciences, Inc. (Nasdaq: CALP ) today announced that its ... on Friday, June 11 at 12:45 p.m. EDT . ... on the company,s business. The live webcast can be accessed at ... , , ...
    Cached Biology Technology:OncoGenex Pharmaceuticals to Present at the 9th Annual Needham Healthcare Conference 2Tianyin Corporate Presentation Updated 2
    (Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
    (Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
    (Date:8/5/2015)... CHICAGO , August 5, 2015 ... Identity & Access Management Market by Software, Services, Vertical (BFSI, ... Chemical/Pharma), & Geography - Global Forecast to 2020", published ... Access Management Market globally into various segments. The global ... in 2014 to $546.2 Million by 2019, at a ...
    Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
    ... Plasmonic gold nanoparticles make pinpoint heating on demand ... to selectively heat diverse nanoparticles that could advance their ... by Dmitri Lapotko and Ekaterina Lukianova-Hleb showed common gold ... heat up at near-infrared wavelengths as narrow as a ...
    ... or when biting into an apple could be an indication ... and support the teeth. Bacterial plaque attacks the bone, meaning ... even fall out, as they are left without a solid ... as a focal point from which disease can spread throughout ...
    ... Research out of the George Washington University (GW), published ... of Sciences ( PNAS ), reveals another piece ... causes behavioral diseases such as autism. Anthony-Samuel LaMantia, Ph.D., ... of Medicine and Health Sciences (SMHS) and director of ...
    Cached Biology News:Nanoparticles reach new peaks 2Nanoparticles reach new peaks 3Quick detection of periodontitis pathogens 2Quick detection of periodontitis pathogens 3GW professor discovers new information in the understanding of autism and genetics 2
    ... a novel procedure for the uniform amplification ... genome DNA from small samples. This method ... and highly reproducible amplification and labeling procedure ... REPLI-g Mini Kit module (QIAGEN) and a ...
    ... Introduction of a protein into cells permits ... signaling pathways, apoptotic pathways, and transcription factor-mediated ... studying the effects of a specific protein ... the protein directly into the cell. ProteoJuice ...
    ... automated instrument with a thin silicon strain ... light or fluorescence microscopy. Biaxial strain that ... cells can be simulated by mechanical stretching ... axis of our strain chamber. Strain can ...
    ... now entered the next frontier of cell-based ... with Cellomics, Inc. The drug discovery process ... Coulter‘s automated solutions systems and Cellomics‘ HCS ... the sub-cellular level. The integration of these ...
    Biology Products: